NFKB1 and Menkes disease: Further, [Lopez-Escamez et al. (6)] highlighted the multifactorial etiology of MD and proposed all individuals with MD symptoms obtain testing for rs4947296, a marker for a potentially treatable NF-kB-mediated inflammatory response and outlined an algorithm to determine candidacy for gene therapy (87).